Effects of Cannabis Species Labeling and Marketing on Perceptual, Subjective and Objective Use Outcomes (Aim 2 Study)
2 other identifiers
interventional
2,000
1 country
1
Brief Summary
This study looks at how cannabis product label and marketing claims affect product perceptions, use expectancies, and use intentions among inexperienced and experienced cannabis users. Participants will answer online survey questions on their perceptions of a cannabis product advertisement.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Apr 2026
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 1, 2026
CompletedFirst Posted
Study publicly available on registry
April 7, 2026
CompletedStudy Start
First participant enrolled
April 15, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
July 1, 2026
May 11, 2026
May 1, 2026
3 months
April 1, 2026
May 7, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (5)
Harm perception - One time use
How harmful participant perceives the product to be after one time use. Participants will answer a survey item, In your opinion, what is the level of risk to one's health from using the product you just viewed one time?; with response options ranging from 0-Very low risk to 4-Very high risk.
Immediately after viewing ad
Harm perception - Daily use
How harmful participant perceives the product to be with daily use. Participants will answer a survey item, In your opinion, what is the level of health risk from using the product you just viewed on a daily basis?; with response options ranging from 0-Very low risk to 4-Very high risk.
Immediately after viewing ad
Expectancy effects
Effects participant expects to feel after using the product. Participants will answer a survey item, Please rate the extent to which you expect to feel each of the following effects \[paranoid; panicked; fearful; anxious; suspicious; like my heart is racing; sluggish; drowsy; out of it; slow; lazy; excited; heightened senses; sociable; creative; wise; in tune with nature; focused; productive; sleepy; happy; euphoric; calm; relaxed; pain-free\] after using the product you just viewed; with response options ranging from 0-not at all to 10-extremely.
Immediately after viewing ad
Willingness to use
How willing participant is to use the product. Participants will answer a survey item, How willing would you be to use the product you just viewed?; with response options ranging from 0-Not at all willing to 4-Very willing.
Immediately after viewing ad
Willingness to use during daily activities
How willing participant is to use the product during daily activities. Participants will answer a survey item, How willing would you be to use the product you just viewed if you \[wanted to concentrate; wanted to relax; wanted to socialize; wanted to do a creative activity (e.g., art, music); wanted to feel happier; wanted to relieve medical symptoms/treat a medical condition/mental health condition; were going to drive a car in the next 30 minutes; were going to bed in the next 30 minutes; were planning to stay home for the next several hours; were going to work in the next 30 minutes; were at a party\]?; with response options ranging from 0-Not at all willing to 4-Very willing.
Immediately after viewing ad
Study Arms (12)
Indica/Energizing
EXPERIMENTALAd features Indica label + energizing claim
Indica/Sedating
EXPERIMENTALAd features Indica label + sedating claim
Indica/No claim
EXPERIMENTALAd features Indica label + no claim
Sativa/Energizing
EXPERIMENTALAd features Sativa label + energizing claim
Sativa/Sedating
EXPERIMENTALAd features Sativa label + sedating claim
Sativa/No claim
EXPERIMENTALAd features Sativa label + no claim
Hybrid/Energizing
EXPERIMENTALAd features Hybrid label + energizing claim
Hybrid/Sedating
EXPERIMENTALAd features Hybrid label + sedating claim
Hybrid/No claim
EXPERIMENTALAd features Hybrid label + no claim
No strain/Energizing
EXPERIMENTALAd features no strain label + energizing claim
No strain/Sedating
EXPERIMENTALAd features no strain label + sedating claim
No strain/No claim
NO INTERVENTIONAd features no strain label + no claim
Interventions
Presentation of strain label on cannabis advertising material
Presentation of claim on cannabis advertising material
Eligibility Criteria
You may qualify if:
- Age = 21+
- Live in in a US state (or Washington D.C.) in which recreational cannabis sale is legal and implemented
- For inexperienced users: lifetime cannabis use \>1 \& \<= 10
- For experienced users: lifetime cannabis use\>10 \& \<100, past month cannabis use\>0
You may not qualify if:
- Under age 21
- Does not live in a US state (or Washington D.C.) in which recreational cannabis sale is legal and implemented
- Lifetime cannabis use \>=100 times
- Lifetime cannabis use \<1 time
- Lifetime cannabis use\>10 \& \<100 AND past month cannabis use=0
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
2213 McElderry St.
Baltimore, Maryland, 21205, United States
Study Officials
- PRINCIPAL INVESTIGATOR
Meghan Moran, PhD
Johns Hopkins University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- FACTORIAL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 1, 2026
First Posted
April 7, 2026
Study Start
April 15, 2026
Primary Completion (Estimated)
July 1, 2026
Study Completion (Estimated)
July 1, 2026
Last Updated
May 11, 2026
Record last verified: 2026-05
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ICF, CSR, ANALYTIC CODE
- Time Frame
- IPD and supporting information will be available as soon as possible, and no later than the time of publication or the end of the funding period, whichever comes first. The duration of preservation and sharing of the data will be a minimum of 10 years after the funding period.
- Access Criteria
- Data from all aims will be deposited in the Johns Hopkins Research Data Repository. This archive provides open access to be downloaded freely by users. The Johns Hopkins Research Data Repository is a searchable archive in which JHU researchers may upload datasets and associated documentation. A persistent identifier (DOI) is provided. Metadata, including searchable keywords, are provided. Data are findable to the public.
Deidentified participant responses will be shared as needed to comply with grant and publication policies.